The Texas Heart Institute Awarded a National Institutes of Health Grant to Advance Organ Bioengineering (IMAGE)
Caption
The Texas Heart Institute recently received a five-year, $2 million grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health to advance the technology supporting development of transplantable bioartificial hearts. The project, funded by a Stephen I. Katz Early Stage Investigator Research Project Grant, will be led by Camila Hochman-Mendez, MSc, PhD, director of Regenerative Medicine Research and the Biorepository and Biospecimen Profiling Core Laboratory. The interdisciplinary research team includes Fernanda Mesquita, PhD, and Ernesto Curty da Costa, MD, PhD, in Regenerative Medicine Research and collaborating investigators Yaxin Wang, PhD, director of the Innovative Device & Engineering Applications (IDEA) Lab, and Mehdi Razavi, MD, director of the Electrophysiology Clinical Research & Innovations group.
Credit
© THE TEXAS HEART INSTITUTE 2023
Usage Restrictions
Photo credit
License
Original content